MEDIZIN

DOC-CHECK LOGIN

Comprehensive Care – difference and common aspects of acute treatment and chronic care

 

From Prof. Dr. Ley Sander, London, UK

 

Berlin (20. September 2008) – Epilepsy is the most common serious neurological disorder with a lifetime prevalence of between two and five percent. Many of those developing epilepsy do so at a young age.  The prevalence of active epilepsy (ie people with ongoing seizures) is up to one percent of the general population. For many people who develop epilepsy, the condition is short lived, but in about one fifth of those who develop epilepsy the condition becomes chronic with little prospect for full seizure remission.

 

Having recurrent epileptic seizures has implications in a number of life domains and these include education, employment, relationships, and leisure. The propensity to recurrent epileptic seizures may curtail someone’s independence and severely impact on quality of life. An acute epilepsy care model may be adequate in treating seizures acutely and may avoid direct medical complications but usually disregards these important aspects of a person’s life. On the other hand, a comprehensive care model provides a holistic approach to the person with the condition.

 

The delivery of comprehensive care involves a multidisciplinary team whilst acute care is usually based on physician only health delivery, focusing mainly on seizure control. This acute approach may well be adequate for those who have a short lived condition. Comprehensive care often involves voluntary agencies and support groups in addition to the multidisciplinary team. The team delivering comprehensive care usually consists of physicians of various disciplines (neurologists, paediatricians, neurophysiologists, neurosurgeons, psychiatrists, and learning disability specialists), epilepsy specialist nurses, therapists (speech, physio, occupational), social workers as well as counsellors. The team has access to full diagnostic facilities and well as to neurosurgical services. Comprehensive care is proactive and will engage in careful planning of a person’s management path. This is in contrast to acute care which is usually reactive and ad hoc. Comprehensive care is better placed to consider, for instance, the feasibility of epilepsy surgery in an individual person and to plan for it. It may also plan ahead for changes in life status of a person (for example, planned pregnancy).  People with well-controlled epilepsy may wish to taper or stop anti-epileptic drug therapy, and this should be the province of comprehensive care. This comprehensive care usually provides full information to the people it serves and will have an open access policy. Comprehensive epilepsy care also involves planned shared care with the primary care provider. There will be a shared-care protocol as well as guidelines for urgent access to the comprehensive care centre.

 

Despite the intuitive feeling that comprehensive care is better than acute care for people with epilepsy, there is no clear evidence to confirm this. Nevertheless, given the opportunity most people with epilepsy would prefer a comprehensive health delivery approach over the option of ad hoc management. A comprehensive approach usually provides continuity of care which is one of the features that people with epilepsy most appreciate in their assessment of health care delivery.

 

This presentation will discuss these issues, comparing and contrasting the acute care delivery approach to a full comprehensive care model for people with epilepsy.

 

Sander_1

 

Slide 1: Scope of epilepsy.

 

 

Sander_2

 

Slide 2: Compehensive care.

 

 

Sander_3

 

Slide 3: Comprehensive epilepsy care.

 

 

Sander_4

 

Slide 4: Comprehensive care better?

 

 

 


 

Source: 8th European Congress on Epiteptology, Satellite Symposium: “Comprehensive Care of Epilepsy in Europe”, Berlin, 20. September 2008 (Medizin und PR Kommunikation).

MEDICAL NEWS

Perinatal patients, nurses explain how hospital pandemic policies failed them
Johns Hopkins Medicine expert creates comprehensive guide to new diabetes…
An amyloid link between Parkinson’s disease and melanoma
Ultrasensitive, rapid diagnostic detects Ebola earlier than gold standard test
Paranoia therapy app SlowMo helps people ‘slow down’ and manage…

SCHMERZ PAINCARE

Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern
Wenn Schmerzen nach einer OP chronisch werden
Deutscher Schmerz- und Palliativtag 2021 – ONLINE: Schmerzmediziner, Politiker und…
Deutscher Schmerz- und Palliativtag 2021 – ONLINE: COVID-19-Pandemie belastet Schmerzpatienten…

DIABETES

„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ meldet…
Kinder und Jugendliche mit Typ-1-Diabetes gehören nicht zur Risikogruppe und…
Neue Studie will Entstehung von Typ-1-Diabetes bei Kindern verhindern
Toujeo®: Ein Beitrag zu mehr Sicherheit für Menschen mit Typ-1-Diabetes
Diabeloops Ziel: Baldige Marktpräsenz mit ​individuellen Lösungen zum Diabetes-Management für​ verschiedene…

ERNÄHRUNG

DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…

ONKOLOGIE

Leberkrebs: Bei welchen Patienten wirkt die Immuntherapie?
Konferenzbericht vom virtuellen Münchener Fachpresse-Workshop Supportive Therapie in der Onkologie
Wie neuartige Erreger die Entstehung von Darmkrebs verursachen können
Onkologische Pflegekräfte entwickeln Hörspiel für Kinder: Abenteuer mit Alfons
Krebsüberleben hängt von der Adresse ab

MULTIPLE SKLEROSE

Multiple Sklerose: Salzkonsum reguliert Autoimmunerkrankung
Erste tierexperimentelle Daten zur mRNA-Impfung gegen Multiple Sklerose
Multiple Sklerose: Immuntherapie erhöht nicht das Risiko für schweren COVID-19-Verlauf
Empfehlung zur Corona-Impfung bei Multipler Sklerose (MS)
Fallstudie: Beeinflusst SARS-CoV-2 Infektion die Multiple Sklerose?

PARKINSON

Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung
Neuer Bewegungsratgeber unterstützt Menschen mit M. Parkinson durch Yoga
Covid-19-Prävention: besondere Vorsicht bei Patienten mit der Parkinson-Krankheit
Neue Studie zur tiefen Hirnstimulation bei Parkinson-Erkrankung als Meilenstein der…